Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
Pascual
José Carlos
JC
Matarredona
Jaime
J
Miralles
Julia
J
Conesa
Venancio
V
Borras-Blasco
Joaquín
J
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000473:pathology; D009059:Mouth Diseases / Q000139:chemically induced* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D014060:Tongue Diseases / Q000139:chemically induced / Q000473:pathology
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate